AnalystsMark BreidenbachMark Breidenbach's Stock Forecasts
AnalystsMark Breidenbach
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4046 out of 4417 analysts
Average Return
-9.4%
Win Rate
25%15 out of 61
Risk vs Reward
Poor
Good
Mark Breidenbach's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Seres Therapeutics IncMCRB | +476.75% | $3.57 | $20.59 | 2020-03-31 - 2021-03-31 | Buy |
Kadmon Holdings IncKDMN | +137.50% | $4.00 | $9.50 | 2021-07-19 - 2021-11-09 | Buy |
Global Blood Therapeutics IncGBT | +126.79% | $30.20 | $68.49 | 2022-02-24 - 2022-10-04 | Buy |
Alpine Immune Sciences IncALPN | +109.80% | $7.45 | $15.63 | 2023-03-24 - 2023-12-01 | Buy |
Essa Pharma IncEPIX | +93.19% | $2.79 | $5.39 | 2023-08-09 - 2023-12-01 | Buy |
Mark Breidenbach Analyst Color
Get additional color on Mark Breidenbach's coverage of popular stocks
Mark Breidenbach's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | 4 | Buy | $22.00 | +40.75% | Maintains | 3 months ago |
Essa Pharma IncEPIX | 3 | Buy | $17.00 | +215.40% | Reiterates | 4 months ago |
Arvinas IncARVN | 5 | Buy | $95.00 | +302.54% | Reiterates | 4 months ago |
Immuneering CorpIMRX | 3 | Buy | $25.00 | +202.30% | Reiterates | 4 months ago |
Allogene Therapeutics IncALLO | 4 | Buy | $28.00 | +1,011.11% | Reiterates | 4 months ago |
Cue Biopharma IncCUE | 5 | Buy | $10.00 | +316.67% | Assumes | 5 months ago |
Seres Therapeutics IncMCRB | 4 | Buy | $12.00 | +1,021.50% | Assumes | 5 months ago |
Nurix Therapeutics IncNRIX | 2 | Buy | $25.00 | +261.79% | Assumes | 5 months ago |
Biolinerx LtdBLRX | 1 | Buy | $4.00 | +163.16% | Reiterates | 6 months ago |
Gamida Cell LtdGMDA | 4 | Buy | $6.00 | +1,718.18% | Maintains | 7 months ago |
Compugen LtdCGEN | 6 | Buy | $7.00 | +898.57% | Maintains | 7 months ago |
Caribou Biosciences IncCRBU | 2 | Buy | $32.00 | +462.39% | Maintains | 9 months ago |
Syros Pharmaceuticals IncSYRS | 3 | Buy | $13.00 | +388.72% | Maintains | 9 months ago |
Iovance Biotherapeutics IncIOVA | 5 | Buy | $15.00 | +139.62% | Maintains | 9 months ago |
Synlogic IncSYBX | 2 | Buy | $120.00 | N/A | Maintains | a year ago |
Forma Therapeutics Holdings IncFMTX | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $86.00 | N/A | Maintains | 2 years ago |
Kadmon Holdings IncKDMN | 1 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Achilles Therapeutics PLCACHL | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Mustang Bio IncMBIO | 2 | Buy | $195.00 | N/A | Maintains | 4 years ago |
Bluebird Bio IncBLUE | 2 | Buy | $135.00 | N/A | Upgrades | 4 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Buy | $6.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.